Ciclesonide titrated against either mannitol AHR or a reference strategy in patients with persistent asthma

Trial Profile

Ciclesonide titrated against either mannitol AHR or a reference strategy in patients with persistent asthma

Completed
Phase of Trial: Phase III

Latest Information Update: 21 Dec 2011

At a glance

  • Drugs Ciclesonide (Primary)
  • Indications Asthma
  • Focus Therapeutic Use
  • Acronyms STAMINA
  • Most Recent Events

    • 21 Dec 2011 New trial record
    • 13 Oct 2011 Results published in Chest.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top